J 2006

A novel form of non-X-linked hyperigm associated with growth and pubertal disturbances and with lymphoma development.

MOSCHESE, Viviana; Jiří LITZMAN; Francesco CALLEA; Loredana CHINI; Rita DEVITO et. al.

Basic information

Original name

A novel form of non-X-linked hyperigm associated with growth and pubertal disturbances and with lymphoma development.

Name in Czech

Nový typ hyper-IgM syndromu nevázaného na chromozóm X s růstovou retardací a vývojem lymfomu

Authors

MOSCHESE, Viviana (380 Italy); Jiří LITZMAN (203 Czech Republic, guarantor); Francesco CALLEA (380 Italy); Loredana CHINI (380 Italy); Rita DEVITO (380 Italy); Rita CARSETTI (380 Italy); Silvia DICESARE (380 Italy); Frederic GEISSMAN (380 Italy); Nicolle BROUSSE (380 Italy); Paolo ROSSI (380 Italy) and Anne DURANDY (250 France)

Edition

J Pediatr, Mosby, 2006, 0022-3476

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

30209 Paediatrics

Country of publisher

United States of America

Confidentiality degree

is not subject to a state or trade secret

Impact factor

Impact factor: 3.991

RIV identification code

RIV/00216224:14110/06:00024058

Organization unit

Faculty of Medicine

UT WoS

000236718700030

Keywords in English

hyper-IgM; immunodeficiency; growth disturbance; lymphoma

Tags

International impact, Reviewed
Changed: 2/4/2010 08:06, prof. MUDr. Jiří Litzman, CSc.

Abstract

In the original language

HyperIgM syndrome is a heterogenous immunodeficiency characterized by impaired class-switch recombination due to different molecular abnormalities. We report on two female patients affected by a novel syndrome associating HIGM, growth and pubertal disturbances, and severe lymphoid hyperplasia with eventual development into lymphomas, suggesting a DNA repair defect.

In Czech

Jsou popsány kazuistiky 2 dívek s hyper IgM syndromem u nichž se objevila porucha růstu. U obou se vyminul v pubertě lymfom.

Links

NR7981, research and development project
Name: Lymfocytární subpopulace u pacientů s humorálními imunodeficity
Investor: Ministry of Health of the CR